logo
Scientists finally know where potatoes come from—and the answer is very weird

Scientists finally know where potatoes come from—and the answer is very weird

New research traces the genetic ancestry of the popular root vegetable to a brief plant romance millions of years ago. A new study shows that the tomato gave rise to the modern clade of potatoes by hybridizing with another ancient plant species millions of years ago. Photograph by Mark Thiessen
Tomato to potato? To-mah-to to po-tah-to? Turns out, we can thank the tomato for our beloved potato.
A new study, published in Cell, has traced the genetic origins of our modern potatoes. The results show that a cross-breeding event eight to nine million years ago between an ancient tomato relative and another ancient plant gave rise to the first potato. That plant romance resulted in a gene combination that grew a thick, starchy tuber—the birth of the iconic spud we all know and love.
How researchers traced the potato's lineage
More than just a delicious ingredient in our favorite meals, potatoes are the world's third most important staple crop. They can grow by sticking part of a tuber in the ground, which grows into another plant—a clone of the first which can accumulate bad mutations over time.
The potato as we know it today contains a lot of harmful mutations that can make the plant more delicate. 'We would like to purge them,' says Sanwen Huang, a genome biologist at Agricultural Genomics Institute at Shenzhen in China, who was involved in the study. He's on a mission to develop a new hybrid potato, one that has fewer bad mutations and can also be grown from seeds, as opposed to modern potatoes, which cannot.
If more potatoes were grown from seeds, scientists could prune out the bad mutations, as well as the dangers from disease that clones are prone to. After all, no one wants another Irish Potato Famine.
Potatoes are in the plant genus Solanum, the same genus responsible for tomatoes, eggplants, and peppers, to name a few. It's 'one of the flowering plant genera that has more than 1,000 species,' explains Sandra Knapp, a plant taxonomist at the Natural History Museum in London, who was involved in the study. Limited Time: Bonus Issue Offer Subscribe now and gift up to 4 bonus issues—starting at $34/year.
Knapp is interested in finding the relationships between the plants in the genus, so she teamed up with Huang. 'He's interested in potatoes. We're interested in Solanum,' Knapp says. 'We realized that there was something interesting here.'
Using full genome sequences, Knapp and her colleagues constructed a family tree with six potato species and compared it with 21 other Solanum species. They also compared another 128 genomes to figure out just how closely potato species aligned with the other species.
Potatoes, they showed, are related both to the tomato group and to another group of plants called Etuberosum. 'It's a little tiny lineage, only three little species,' Knapp says.
Above ground, Etuberosum look just like potatoes, but unlike the modern potatoes, ancient and modern Etuberosums and tomatoes can't make tubers.
But when that ancient tomato and an Etuberosum crossed all those years ago, a hybrid group called 'Petota' was formed. This new group gave way to the tuber.
The science of spuds
But if the ancient tomato and Etuberosum couldn't produce tasty tubers, why could Petota? The scientists found the new group inherited a mix of genes from the two ancient plant groups that produced a strong spud. For example, the tomato donated SP6A, a gene that turns on tuberization (yes, that's the technical term). Meanwhile, Etuberosum brought IT1 to the table, which controls tuber growth.
This genetic jumble came at just the right time. The tomato group of plants generally prefers hot and dry conditions, Knapp notes, while Etuberosum likes it cold and wet. But around 10 million years ago, the Andes mountain range began to rise up on the Western coast of South America.
The new heights offered conditions that were cold, but also dry. Petota's energy-storing tubers 'allowed these new plants to expand into these new environments in the high Andes,' Knapp explains.
The future of potatoes
Many times, hybridization doesn't have a good outcome, notes James Mallet, an evolutionary biologist at Harvard University, who was not involved in the research.
'It's not good to kind of make a mess of your genes like that,' he says. But 'occasionally you will get weird combinations of genes that couldn't have evolved within each lineage—it's like you're shaking the dice again.' Those new combinations could make a big difference if there are new habitats to colonize, possibly allowing new species to arise.
And arise they did. Today, there are 107 wild potato species.
Ole Seehausen, an evolutionary ecologist at the University of Bern in Switzerland, says the study is the first time someone has shown a key evolutionary invention—the tuber—produced by the hybridization of two species. Those tubers themselves, he notes, could have helped the potatoes succeed after that shake of the genetic dice.
Reproducing by tuber alone has its downsides for disease. But it also means the new Petota didn't immediately need to mate to pass on its new genetic tangle. The ability to clone itself 'allows hybrid lineages that….really cannot sexually reproduce, to still survive,' he notes, until it could regain fertility.
Huang hopes to use the new understandings of the tomato-to-potato path to potentially create healthier potato plants. He could use the tomato plant as a platform for new genes, and reintroduce them to the potato, he says, 'as tomato is essentially free of deleterious mutations.'
In the end, he hopes to make potato seeds—human-driven hybridization to help our French fries clean out their harmful mutations.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Cell Dissociation Market Size Projected to Attain USD 1,451.89 Million by 2034
Cell Dissociation Market Size Projected to Attain USD 1,451.89 Million by 2034

Yahoo

timea day ago

  • Yahoo

Cell Dissociation Market Size Projected to Attain USD 1,451.89 Million by 2034

The global cell dissociation market is valued at USD 461.55 million in 2025 and is projected to reach approximately USD 1,451.89 million by 2034, expanding at a CAGR of 13.58% during the forecast period. Ottawa, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The global cell dissociation market size valued at USD 406.36 million in 2024, is projected to reach approximately USD 1,451.89 million by 2034, growing at a CAGR of 13.58%, according to a study by , a sister company of Precedence Research. Widespread application of cell dissociation in diagnostics, study of diseases, isolation of various cell products, etc, due to which the cell dissociation market is progressing. The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ Key Takeaways North America led the market share by 38% in 2024. Asia Pacific is expected to be the fastest-growing region in the coming years. By product, the enzymatic dissociation segment dominated the cell dissociation market in 2024. By product, the non-enzymatic dissociation segment is expected to grow at the fastest CAGR during 2025-2034. By type, the tissue dissociation segment held a major share of the market in 2024. By type, the cell detachment segment is expected to witness rapid expansion in the studied years. By end-user, the pharmaceutical & biotechnology companies segment led the cell dissociation market in 2024 and is expected to grow rapidly during the forecast period. Market Overview & Potential The process in which individual cells are separated from a tissue or cell culture, usually for research or therapeutic applications, is known as cell dissociation. Primarily, they are employed in stem cell research, cancer research, tissue engineering, and drug discovery. Currently, the cell dissociation market is experiencing progression in enzymatic and mechanical methods, as well as the involvement of innovative technologies, such as portable electrical devices. Basic use of cell dissociation in the development of regenerative medicine encompasses cell isolation, manipulation, and then reintroduction into the body. Market Scope Metric Details Market Size in 2024 USD 406.36 Million Projected Market Size in 2034 USD 1451.89 Million CAGR (2025 - 2034) 13.58 % Leading Region North America Market Segmentation By Product, By Type, By End-use, By Region Top Key Players Merck KGaA, Thermo Fisher Scientific, Danaher Corp., STEMCELL Technologies, Sartorius AG, BD, Miltenyi Biotec, PAN-Biotech, HiMedia Laboratories, F. Hoffmann-La Roche Ltd., S2 Genomics, Inc. What are the Key Growth Drivers Involved in The Expansion of The Market? Around the world, the developing utilization of cell-based assays in drug discovery and development, as well as in customized medicine, is leading to an increased demand for robust cell dissociation products. The cell dissociation market is further driven by tremendous applications in the escalating demand for cell-based therapies, especially stem cell and gene therapies. Besides this, advancing research techniques, like automation and integration with omics technologies, are supporting process efficiency and further expansion of the market. You can place an order or ask any questions, please feel free to contact us at sales@ What Are the Trends Associated with the Cell Dissociation Market? In 2025, the growing emergence of numerous biotechnology and pharmaceutical industries in research and development is impacting the overall market growth. In July 2025, SPT Labtech, a global company in innovative laboratory automation, collaborated with Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory, to advance automated cell-based assay workflows. In April 2025, EditCo Bio, Inc. and Promega Corporation partnered to empower the era of biologically related cell-based research, such as HiBiT, HaloTag®, and NanoLuc® technologies. In November 2024, Singleron Biotechnologies, a player in single-cell analysis solutions, made a partnership with TOMY Digital Biology Co., Ltd to enable access to Singleron's comprehensive range of single-cell analysis products and services. What Is the Major Limitation in the Market? The cell dissociation market is facing certain challenges, mainly the maintenance of high cell viability and purity after the dissociation process in the production of biopharmaceuticals and cell-based therapies. Besides this, expensive specialized enzymes, automated systems, and other reagents are creating a hindrance to developing cell dissociation technologies. Regional Analysis Become a valued research partner with us - Why did North America Dominate the Cell Dissociation Market in 2024? The market is propelled by immense investments in life sciences research in this region, impacting market development, primarily in the US. Moreover, this region possesses advanced biotechnology and a pharmaceutical industry, and a strong healthcare infrastructure. Along with this, North America's emphasis on the development of precision medicine, 3D cell culture models, and advanced therapies like gene editing is expanding demand for more sophisticated and effective cell dissociation solutions. For instance, In March 2025, RoslinCT and Ayrmid Pharma made a strategic partnership for the production of Omisirge®, a treatment for hematologic malignancies commercialized in the United States by Gamida Cell, a subsidiary of Ayrmid Pharma. In October 2024, FibroBiologics Inc., a clinical-stage biotechnology company, and Charles River Laboratories, a leading drug discovery, development, testing, and manufacturing solutions provider, signed an agreement to develop and manufacture FibroBiologics' therapeutic master cell bank, working cell bank, and fibroblast-based spheroids product, CYWC628. What Made the Asia Pacific Significantly Grow in the Market in 2024? During 2025-2034, the Asia Pacific will expand at the fastest CAGR in the cell dissociation market. Combined factors are impacting the overall market expansion in the ASAP countries, such as China. Japan, India, and South Korea. An expanding healthcare system, with increased focus on R&D, especially in regenerative medicine and stem cell research, is widely involved in the market expansion. Apart from this, ongoing government initiatives to boost the biotechnology domain and accelerate the pipeline in clinical research activities are also propelling the adoption of innovative technologies. For this market, In August 2025, CytoNiche Biotech, a leader in 3D cell production technology, inaugurated its 3D FloTrix™ Experience Hub in Singapore. In July 2025, NKGen Biotech, Inc., a clinical-stage biotechnology company, and Japan-based HekaBio K.K., partnered to expand the regulatory, manufacturing, and commercial development of NKGen's autologous NK cell therapy, troculeucel, in Japan following HekaBio's recently announced investment in common equity of NKGen. Get the latest insights on life science industry segmentation with our Annual Membership: Segmental Insights By product analysis How did the Enzymatic Dissociation Segment Lead the Market in 2024? In 2024, the enzymatic dissociation segment registered dominance in the cell dissociation market. This type of product can give higher cell yield with broader effectiveness at extracting cells from dense or complex tissues as compared to other mechanical methods. Moreover, this approach offers its flexibility in different downstream applications, like flow cytometry, cell sorting, and in vitro assays. Alongside its wide-range utilization in the development of numerous cell-based therapies and its ability to minimize the amount of fibrous connective tissue present in the cell suspension, it boosts further cell viability and downstream analysis in the market. However, the non-enzymatic dissociation segment is predicted to experience rapid growth in the studied years. This product type has several advantages, like it can preserve cell surface proteins, which is vital for downstream assays. Furthermore, non-enzymatic dissociation is favourable for sensitive cells. Also, they are obtained without animal-derived components, making them adaptable for various cell-based therapies is driving overall segment and market expansion. Whereas, non-enzymatic dissociation is greatly employed in isolating and expanding MSCs while protecting their key functional properties. By type analysis Which Type Held the Largest Share of the Cell Dissociation Market in 2024? The tissue dissociation segment dominated the market with a major share in 2024. The segment is driven by rising research in oncology, chronic conditions, and breakthroughs in cell-based therapies. This type mainly contributes to the separation of cells from a tissue sample to create a single-cell suspension, which is further necessary for isolating cells for therapeutic use, research, and diagnostics. Moreover, the cell detachment segment is estimated to grow fastest during 2025-2034. The significance of cell detachments in cell culture, particularly in culturing adherent cells, is increasingly applied in many research and therapeutic applications. Along with this, a rise in demand for monoclonal antibodies in biopharmaceutical and pharmaceutical industries is immensely dependent on cell culture and, consequently, cell detachment techniques. Eventually, they encompass mechanical detachment (scraping or shaking) and physical methods, such as thermal, light, or magnetic manipulation, which can be selected based on the cell type, culture conditions, and downstream applications. By end-user analysis What Made the Pharmaceutical & Biotechnology Companies Segment Dominate in the Market in 2024? The pharmaceutical & biotechnology companies segment was dominant in the cell dissociation market in 2024 and will expand at the fastest CAGR. Widespread use of cell dissociation is seen in these companies, particularly in vaccine development, production of diverse biopharmaceutical products, and cancer research. Additionally, the segment is fueled by the adoption of cell dissociation in drug discovery and development, allowing the generation of single-cell suspensions, which are essential for high-throughput screening of possible drug candidates. The utilization of the single-cell RNA sequencing (scRNA-seq) technique relies on cell dissociation for the analysis of gene expression profiles in individual cells, demonstrating significant insights into drug responses and cellular heterogeneity. Recent Developments in the Cell Dissociation Market In July 2025, AscellaHealth, a leading partner delivering customizable solutions to support the specialty pharmaceutical industry, partnered with Abeona Therapeutics Inc. for pre- and post-launch commercialization of ZEVASKYN™, an FDA-approved cell-based gene therapy. In April 2025, Singleron Biotechnologies launched PythoN i, an advanced tissue having in nuclei extraction and tissue homogenization functions to its tissue processing system. In March 2025, Sphere Bio, a major provider of innovative picodroplet-based microfluidics solutions for functional single-cell analysis and isolation, introduced the Cyto-Cellect® Human IgG Kappa and Viability Assay Kit, the first multiplexed assay developed specifically for the Company's new Cyto-Mine® Chroma platform. In April 2024, Kuraray Co., Ltd. developed PVA (Polyvinyl Alcohol) hydrogel microcarriers for cell cultures used in regenerative medicine. Browse More Insights of Towards Healthcare: The global single-cell sequencing market was valued at US$ 1.63 billion in 2024 and is anticipated to rise to US$ 1.88 billion by 2025. By 2034, the market is projected to exceed US$ 6.65 billion, advancing at a CAGR of 15.05%. The global cellular immunotherapy market reached US$ 11.33 billion in 2024 and is expected to grow to US$ 13.87 billion in 2025, before surging to nearly US$ 85.78 billion by 2034, expanding at a robust CAGR of 22.45% during the forecast period. The global cell and gene therapy clinical trials market was valued at US$ 10.8 billion in 2024, grew to US$ 12.47 billion in 2025, and is projected to achieve US$ 45.31 billion by 2034, registering a CAGR of 15.43% from 2025 to 2034. The global cell-based assays market stood at US$ 17.29 billion in 2024 and is forecast to increase to US$ 18.82 billion in 2025. By 2034, it is anticipated to surpass US$ 39.92 billion, advancing at a CAGR of 8.84%. The global biopharmaceutical contract manufacturing market was calculated at US$ 40.14 billion in 2024, expanded to US$ 44.61 billion in 2025, and is projected to reach approximately US$ 115.65 billion by 2034, growing at a CAGR of 11.14% between 2025 and 2034. The global cell and gene solutions market is on a strong growth trajectory, with revenue expected to scale significantly over the forecast years from 2025 to 2034, potentially reaching into the hundreds of millions. The global cell-based immunotherapies market was valued at US$ 4.59 billion in 2024, is set to grow to US$ 5.28 billion in 2025, and is projected to generate US$ 18.62 billion by 2034, expanding at a CAGR of 15.02% throughout the forecast period. The global cell banking outsourcing market reached US$ 14.37 billion in 2024, expanded to US$ 16.72 billion in 2025, and is forecast to hit US$ 63.49 billion by 2034, growing at a strong CAGR of 16.37%. The global stem cell banking market was valued at US$ 7.85 billion in 2024, grew to US$ 9.12 billion in 2025, and is projected to climb to US$ 35.12 billion by 2034, advancing at a CAGR of 16.14% between 2025 and 2034. The global host cell protein testing market stood at US$ 2.37 billion in 2024, increased to US$ 2.56 billion in 2025, and is projected to cross US$ 5.19 billion by 2034, expanding at a CAGR of 8.17%. The global stem cell assay market was valued at US$ 2.68 billion in 2024, grew to US$ 3.15 billion in 2025, and is expected to achieve US$ 13.5 billion by 2034, rising at a significant CAGR of 17.55%. The global live cell imaging market reached US$ 2.92 billion in 2024, expanded to US$ 3.16 billion in 2025, and is anticipated to generate US$ 6.49 billion by 2034, progressing at a CAGR of 8.34%. The global immortalized cell line market was valued at US$ 4.55 billion in 2024, increased to US$ 4.85 billion in 2025, and is projected to attain US$ 8.68 billion by 2034, advancing at a CAGR of 6.71%. The global cell viability assays market stood at US$ 1.89 billion in 2024, grew to US$ 2.05 billion in 2025, and is projected to reach US$ 4.24 billion by 2034, expanding at a CAGR of 8.54%. The global stem cell reconstructive market was valued at US$ 1.56 billion in 2024, is forecast to grow to US$ 1.88 billion in 2025, and is expected to achieve US$ 10.32 billion by 2034, advancing at an impressive CAGR of 20.81%. Cell Dissociation Market Key Players Merck KGaA Thermo Fisher Scientific Danaher Corp. STEMCELL Technologies Sartorius AG BD Miltenyi Biotec PAN-Biotech HiMedia Laboratories F. Hoffmann-La Roche Ltd. S2 Genomics, Inc. Segments Covered in The Report By Product Enzymatic Dissociation Trypsin Collagenase Elastase Papain Hyaluronidase DNase Others Non-enzymatic dissociation Instruments & Accessories By Type Tissue Dissociation Cell Detachment By End-use Pharmaceutical & Biotechnology Companies Research & Academic Institutes By Region North America U.S. Canada Mexico Europe Germany UK Spain Italy France Denmark Norway Sweden Asia Pacific Japan China India Australia Thailand South Korea Latin America Brazil Argentina MEA South Africa Saudi Arabia UAE Kuwait Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway. Access the Dashboard: Immediate Delivery Available | Buy This Premium Research @ About Us Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth. You can place an order or ask any questions, please feel free to contact us at sales@ Europe Region: +44 778 256 0738 North America Region: +1 8044 4193 44 Web: Our Trusted Data Partners Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | PinterestError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Man Grooms Golden Retriever, Viewers Not Prepared Who Turns Up
Man Grooms Golden Retriever, Viewers Not Prepared Who Turns Up

Newsweek

timea day ago

  • Newsweek

Man Grooms Golden Retriever, Viewers Not Prepared Who Turns Up

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. In a viral video, a dog owner from Indiana can be seen brushing his golden retriever's fur on the balcony when an unusual guest makes a quick appearance. Shared in April under the username @benshrack, the Instagram clip shows the poster throwing some of his dog's fur off the balcony, only to be immediately picked up by a bird, probably gathering materials to build its nest. "In case you didn't believe how quickly the birds will randomly show up for his fur," the poster writes in the caption. Birds build nests not to live in them, but to make a safe environment for laying eggs, incubating them, and raising their chicks, says the Natural History Museum. These nests vary widely depending on the species, ranging from simple scrapes on the ground to carefully crafted structures. Common materials used in nest construction include sticks, mud, bark, lichen, spider silk, and more. One familiar type is the cup nest, commonly built by birds such as robins and blackbirds. The time required to build a nest also changes, depending on the bird species and environmental conditions. Birds often reuse nests from previous breeding seasons but tend to remove old materials, especially the top layer, to eliminate parasites. However, some birds may retain the lower layers to save time. Nest-building involves both learned behavior and adaptation; birds may modify their construction methods based on surrounding conditions, including parasite levels. To support nesting birds, it is crucial not to disturb them and to stay away from nests. People can assist by providing natural nesting materials such as sticks, dry grass, cotton fluff, or feathers during the spring. Pet owners should be cautious when letting cats or dogs outside near nests. Additionally, installing nest boxes for swifts or garden birds can offer extra nesting options, especially in urban or less-natural environments. Stock image: A man cleans fur off a brush after grooming a golden retriever. Stock image: A man cleans fur off a brush after grooming a golden retriever. getty images The video quickly went viral on social media and has so far received over 5.2 million views and more than 246,000 likes on the platform. One user, commented: "We do this and I actually found a bunny nest that was lined with my late dog's fur in our backyard and I cried. She was keeping those baby bunnies warm even after she passed." Gayathri.v23 posted: "In this economy nest material is probably hard to come by …" Austinraab_ added: "Obtaining golden retriever fur must be like gathering dragon scales for birds." Newsweek reached out to @benshrack for comment via instagram messages. We could not verify the details of the case. Do you have funny and adorable videos or pictures of your pet you want to share? Send them to life@ with some details about your best friend, and they could appear in our Pet of the Week lineup.

Potatoes May Have Evolved From An Unexpected Origin, New Research Shows
Potatoes May Have Evolved From An Unexpected Origin, New Research Shows

Yahoo

time3 days ago

  • Yahoo

Potatoes May Have Evolved From An Unexpected Origin, New Research Shows

New research has revealed an intriguing and unexpected discovery about potatoes. Despite being vastly different from the juicy, red fruits that we know as tomatoes, researchers say that the potato and tomato appear to share an ancient relative, and that potatoes actually evolved from wild tomatoes. The research, which is published in the journal Cell, describes how the scientists analyzed over 450 genomes from cultivated potatoes and 56 from wild potatoes. Looking at that genome, they discovered that over 9 million years ago, wild tomatoes crossed with another ancient plant called Etuberosum. The two plants mixed using a technique called hybridization, effectively combining their genetic structures to create an entirely new plant. The research is a landmark in understanding the origin of the potato and goes a long way toward showing just how creative natural evolution can be at creating entirely new species of living things. Further, without two very specific genes -- one of which is found in tomatoes and one which is found in Etuberosum -- the structure of tubers like potatoes would not be possible at all. Read more: What's Happening To Earth Right Now Can't Be Explained By Climate Models Ancient Parents The researchers say that we're essentially looking at the parents of the modern potato. The wild tomato is the mother, while Etuberosum is the father. Together, they were able to work together to create an entirely new organ, which then expanded into its own lineage of plants. It's an exceptionally intriguing find that will only help us better understand how hybridization events like this helped shape the modern world of vegetables, fruits, and other plants. The researchers also note that potatoes inherited an especially stable mix of genes from both of its parents, allowing it to become a nutrient-rich plant thanks to its tubers, which also allow it to be a sturdy and resilient plant. And the potato is exceptionally resilient. It's one of the first plants we've proven could survive on Mars. Scientists have even used them to create potato-based concrete that could be used to build structures on Mars. But understanding where it came from can help us better unlock the history of our planet, something scientists have been working to do for hundreds of years now. And when it comes to the potato, its history and ancient parentage are anything but what we expected. Enjoyed this article? Sign up to BGR's free newsletter for the latest in tech and entertainment, plus tips and advice you'll actually use. Read the original article on BGR. Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store